Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro

T Saeki1, A Mhashilkar, S Chada

  • 1Section of Thoracic Molecular Oncology, Department of Thoracic and Cardiovascular Surgery, The University of Texas, MD Anderson Cancer Center, TX 77030, USA.

Gene Therapy
|February 15, 2001
PubMed

Insights

Melanoma differentiation-associated gene-7 (mda-7) gene therapy suppressed non-small cell lung cancer (NSCLC) cell growth and induced cell cycle arrest. Apoptosis was triggered via p53-dependent and independent pathways, suggesting Ad-mda-7 as a novel cancer therapy.

Area of Science:

  • Molecular biology
  • Cancer research
  • Gene therapy

Background:

  • Melanoma differentiation-associated gene-7 (mda-7) inhibits tumor growth but its mechanisms are unknown.
  • mda-7 was cloned from a human melanoma cell line.

Purpose of the Study:

  • Investigate the molecular mechanisms of mda-7 in non-small cell lung carcinoma (NSCLC) cells.
  • Determine the role of p53 in mda-7-induced effects.

Main Methods:

  • Overexpression of mda-7 protein using Ad-mda-7 in NSCLC cell lines (wild-type p53 and p53-null) and normal lung fibroblasts.
  • Analysis of cell proliferation, cell cycle arrest, and apoptosis-related protein expression (p53, Bax, Bak, caspase cascade, PARP).

Main Results:

  • Ad-mda-7 suppressed proliferation and induced G2/M arrest in NSCLC cells, but not normal fibroblasts.
  • p53, Bax, and Bak were upregulated in wild-type p53 cells, indicating p53 pathway involvement.
  • Caspase activation and PARP cleavage were independent of p53 status, suggesting multiple apoptotic pathways.

Conclusions:

  • Ad-mda-7 induces apoptosis in lung cancer cells through multiple pathways, irrespective of p53 status.
  • Ad-mda-7 shows potential as a novel therapeutic agent for clinical cancer gene therapy.

Related Concept Videos